De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 13, Issue 6, Pages 575-585
Publisher
Future Science Ltd
Online
2021-02-17
DOI
10.4155/fmc-2020-0262
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Deep Learning Approach to Antibiotic Discovery
- (2020) Jonathan M. Stokes et al. CELL
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Coronavirus puts drug repurposing on the fast track
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Advance of promising targets and agents against COVID-19 in China
- (2020) Yongtao Duan et al. DRUG DISCOVERY TODAY
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- GuacaMol: Benchmarking Models for de Novo Molecular Design
- (2019) Nathan Brown et al. Journal of Chemical Information and Modeling
- Deep learning enables rapid identification of potent DDR1 kinase inhibitors
- (2019) Alex Zhavoronkov et al. NATURE BIOTECHNOLOGY
- De novo characterization of the Baphicacanthus cusia(Nees) Bremek transcriptome and analysis of candidate genes involved in indican biosynthesis and metabolism
- (2018) Wenjin Lin et al. PLoS One
- Recent advances in fragment-based computational drug design: tackling simultaneous targets/biological effects
- (2018) Alejandro Speck-Planche Future Medicinal Chemistry
- Fréchet ChemNet Distance: A Metric for Generative Models for Molecules in Drug Discovery
- (2018) Kristina Preuer et al. Journal of Chemical Information and Modeling
- Deep reinforcement learning for de novo drug design
- (2018) Mariya Popova et al. Science Advances
- SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping
- (2018) Yang Wu et al. NUCLEIC ACIDS RESEARCH
- Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells
- (2017) Beixian Zhou et al. JOURNAL OF ETHNOPHARMACOLOGY
- De novo computational design of compounds virtually displaying potent antibacterial activity and desirable in vitro ADMET profiles
- (2017) Alejandro Speck-Planche et al. MEDICINAL CHEMISTRY RESEARCH
- Speeding up Early Drug Discovery in Antiviral Research: A Fragment-Based in Silico Approach for the Design of Virtual Anti-Hepatitis C Leads
- (2017) Alejandro Speck-Planche et al. ACS Combinatorial Science
- Molecular de-novo design through deep reinforcement learning
- (2017) Marcus Olivecrona et al. Journal of Cheminformatics
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
- (2016) Tomonari Muramatsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enabling the Discovery and Virtual Screening of Potent and Safe Antimicrobial Peptides. Simultaneous Prediction of Antibacterial Activity and Cytotoxicity
- (2016) Valeria V. Kleandrova et al. ACS Combinatorial Science
- Organic Carbamates in Drug Design and Medicinal Chemistry
- (2015) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- A unified lead-oriented synthesis of over fifty molecular scaffolds
- (2015) Richard G. Doveston et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
- (2013) Rolf Hilgenfeld et al. ANTIVIRAL RESEARCH
- Synthesis of libraries of peptidomimetic compounds containing a 2-oxopiperazine unit in the main chain
- (2013) Sujit Suwal et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- ChEMBL: a large-scale bioactivity database for drug discovery
- (2011) A. Gaulton et al. NUCLEIC ACIDS RESEARCH
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- An evaluation of the implementation of the Cramer classification scheme in the Toxtree software
- (2008) G. Patlewicz et al. SAR AND QSAR IN ENVIRONMENTAL RESEARCH
- Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
- (2007) Ruth Brenk et al. ChemMedChem
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started